Skip to main content
Satellos Bioscience Inc. logo

Satellos Bioscience Inc. — Investor Relations & Filings

Ticker · MSCL ISIN · CA80401L3083 TSX Professional, scientific and technical activities
Open in API
Filings indexed 216 across all filing types
Latest filing 2025-08-05 Investor Presentation
Country CA Canada
Listing TSX MSCL

About Satellos Bioscience Inc.

https://satellos.com/

Satellos Bioscience Inc. is a clinical-stage biotechnology company focused on developing regenerative small molecule therapeutics for degenerative muscle diseases, primarily Duchenne muscular dystrophy (DMD). The company's core mission is to restore the body's natural ability to regenerate muscle, addressing the failure of muscle repair inherent in these conditions. Satellos utilizes a novel approach rooted in muscle biology, focusing on restoring the asymmetric division of muscle stem cells (satellite cells), a process disrupted by the absence of dystrophin in DMD. Their strategy involves targeting the AAK1 protein to reactivate the natural repair mechanism. The lead therapeutic candidate, SAT-3247, is currently advancing into a Pediatric Phase 2 clinical study for DMD.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Investor Presentation Classification · 1% confidence The document is a press release announcing that Satellos management will present at the Canaccord Genuity 45th Annual Growth Conference. It is not a full financial report or transcript, but rather an announcement of an upcoming presentation aimed at investors. Therefore it best fits the “Investor Presentation” category (IP).
2025-08-05 English
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a corporate press release announcing the appointment of a new Chief Medical Officer. It details a senior management change (appointment of Dr. Wildon Farwell as CMO) rather than financial results, governance policies, or other filings. This matches the definition of Board/Management Information (MANG).
2025-07-16 English
Report of voting results.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “Report of Voting Results” and provides detailed voting outcomes for director elections, auditor appointment, and a special resolution adopted at the annual and special meeting of shareholders on June 18, 2025. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement. It is not a proxy statement, but the official results publication after the meeting. Therefore, it is classified as DVA.
2025-06-18 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release announcing the detailed voting results from Satellos Bioscience’s Annual and Special Meeting of Shareholders, including director election tallies, approval of a reverse stock split, and auditor re-appointment. It clearly falls under "Declaration of Voting Results & Voting Rights Announcements" (DVA).
2025-06-18 English
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release announcing the election of two new members to the company’s Board of Directors and noting directors who did not stand for re-election. This is a clear announcement of changes in the company’s board, matching the Board/Management Information category.
2025-06-18 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Business Wire press release detailing Phase 1b clinical trial results for SAT-3247 in Duchenne muscular dystrophy patients. It is not a financial report (10-K, IR), earnings release, management change, call transcript, or other predefined category. It is a general corporate announcement regarding clinical data rather than a formal regulatory filing or investor presentation. Therefore, it falls into the fallback category of Regulatory Filings (RNS).
2025-05-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.